Advertisement
Table 3 Phone-based survey of treatment outcomes of EIB and TB-AOI cases - Alberta, 2004–14
| EIB (n = 21) | TB-AOI (n = 20) | |
|---|---|---|
| Phone Follow-up – no. (%) | n = 13 (62) | n = 11 (55) |
| Time post ATT – month (year) | ||
| Median | 61 (5.1) | 49 (4.1) |
| IQR | 34 (2.8) | 48 (4) |
| Responses | ||
| “Do you still have (EIB/TB-AOI)?” | ||
| Resolved – no. (%) | 8 (62) | 2 (18) |
| Better | 2 (15) | 3 (28) |
| Worse | 0 (0) | 0 (0) |
| No change | 3 (23) | 6 (54) |
| “How did your condition respond to the ATT?” | ||
| Min (< 25% improvement) | 1 (8) | 8 (73) |
| Mod (~ 50%) | 1 (8) | 1 (9) |
| Significantly (~ 75%) | 2 (15) | 0 (0) |
| Complete (100%) | 7 (54) | 2 (18) |
| “How did you tolerate the ATT?” | ||
| Poorly | 5 (38) | 3 (28) |
| Well | 5 (38) | 2 (18) |
| No issue | 3 (24) | 6 (54) |
